Novartis AG to acquire CoStim Pharmaceuticals Inc. in an attempt to expand immunotherapy reach
February 17, 2014 2:10 pm
Novartis AG made an official announcement, saying that it reached an agreement to purchase CoStim Pharmaceuticals Inc. in order to expand its reach in immunotherapeutics. The latter is considered to be a new field of cancer drugs and is projected to reach 35 billion dollars in annual sales. Novartis, which is based in Basel, Switzerland, […] Read more